nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A New Reality for Multiple Myeloma Renal Failure: US Data Report on Kidney Transplant Outcomes
|
Dykes, Kaitlyn |
|
|
22 |
5 |
p. e314-e320 |
artikel |
2 |
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group
|
Michallet, Mauricette |
|
|
22 |
5 |
p. 311-318 |
artikel |
3 |
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
|
Bennani, N. Nora |
|
|
22 |
5 |
p. e300-e309 |
artikel |
4 |
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma
|
Zhao, Yue |
|
|
22 |
5 |
p. e310-e313 |
artikel |
5 |
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
|
Costa, Luciano J. |
|
|
22 |
5 |
p. 326-335 |
artikel |
6 |
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients
|
Al-Shaibani, Eshrak |
|
|
22 |
5 |
p. e327-e334 |
artikel |
7 |
COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination
|
Shah, Mansi R. |
|
|
22 |
5 |
p. e321-e326 |
artikel |
8 |
Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States
|
Dhakal, Prajwal |
|
|
22 |
5 |
p. 319-325 |
artikel |
9 |
Editorial Board
|
|
|
|
22 |
5 |
p. A1-A2 |
artikel |
10 |
Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
|
Ehsan, Hamid |
|
|
22 |
5 |
p. e285-e292 |
artikel |
11 |
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations
|
Polprasert, Chantana |
|
|
22 |
5 |
p. e293-e299 |
artikel |
12 |
Infectious Complications Among Patients With AML Treated With Immune Checkpoint Inhibitors
|
Spallone, Amy |
|
|
22 |
5 |
p. 305-310 |
artikel |
13 |
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
|
Jurczyszyn, Artur |
|
|
22 |
5 |
p. 297-304 |
artikel |
14 |
Prognostic Role of "Radiological" Sarcopenia in Lymphoma: A Systematic Review
|
Albano, Domenico |
|
|
22 |
5 |
p. e340-e349 |
artikel |
15 |
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 – 100 × 109/L): Final Analysis of an Open-Label Phase 2 Study
|
Talpaz, Moshe |
|
|
22 |
5 |
p. 336-346 |
artikel |
16 |
SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas
|
Qiu, Lianqun |
|
|
22 |
5 |
p. 287-296 |
artikel |
17 |
SOHO State of the Art Updates and Next Questions: Treatment of Older, Vulnerable Adults with Multiple Myeloma
|
Grant, Shakira J. |
|
|
22 |
5 |
p. 279-286 |
artikel |
18 |
State-of-the-Art Review on Myelofibrosis Therapies
|
Wang, Fuping |
|
|
22 |
5 |
p. e350-e362 |
artikel |
19 |
Table of Contents
|
|
|
|
22 |
5 |
p. A3-A4 |
artikel |
20 |
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
|
Caimi, Paolo F. |
|
|
22 |
5 |
p. e335-e339 |
artikel |